{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:00:59Z","timestamp":1772557259459,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Emerg Med"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s43678-025-01024-y","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:12:13Z","timestamp":1761199933000},"page":"100-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Just the facts: approach to adult patients with immune thrombocytopenic purpura in the emergency department"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-8869","authenticated-orcid":false,"given":"Brit","family":"Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Khalife","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"issue":"11","key":"1024_CR1","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386\u201393.","journal-title":"Blood"},{"issue":"10","key":"1024_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019;381(10):945\u201355.","journal-title":"N Engl J Med"},{"issue":"11","key":"1024_CR3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1080\/17474086.2021.1995347","volume":"14","author":"J Bussel","year":"2021","unstructured":"Bussel J, Cooper N, Boccia R, et al. Immune thrombocytopenia. Expert Rev Hematol. 2021;14(11):1013\u201325.","journal-title":"Expert Rev Hematol"},{"issue":"22","key":"1024_CR4","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780\u2013817.","journal-title":"Blood Adv"},{"issue":"1","key":"1024_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.revmed.2020.05.018","volume":"42","author":"G Moulis","year":"2021","unstructured":"Moulis G, Comont T, Adoue D. Actualit\u00e9s de l\u2019\u00e9pid\u00e9miologie du purpura thrombop\u00e9nique immunologique de l\u2019adulte: Impact pour la pratique clinique [New insights into the epidemiology of immune thrombocytopenia in adult patients: Impact for clinical practice]. Rev Med Interne. 2021;42(1):11\u20135.","journal-title":"Rev Med Interne"},{"key":"1024_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2141.2009.07615.x","volume":"145","author":"WM Schoonen","year":"2009","unstructured":"Schoonen WM, Kucera G, Coalson J, et al. Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol. 2009;145:235\u201344.","journal-title":"Br J Haematol"},{"key":"1024_CR7","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1182\/blood.V94.3.909.415k02_909_913","volume":"94","author":"H Frederiksen","year":"1999","unstructured":"Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood. 1999;94:909\u201313.","journal-title":"Blood"},{"issue":"8","key":"1024_CR8","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/jth.15368","volume":"19","author":"E Sirotich","year":"2021","unstructured":"Sirotich E, Guyatt G, Gabe C, et al. Definition of a critical bleed in patients with immune thrombocytopenia: communication from the ISTH SSC subcommittee on platelet immunology. J Thromb Haemost. 2021;19(8):2082\u20138.","journal-title":"J Thromb Haemost"},{"issue":"23","key":"1024_CR9","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al. American society of hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829\u201366.","journal-title":"Blood Adv"},{"issue":"10","key":"1024_CR10","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2352-3026(16)30109-0","volume":"3","author":"S Mithoowani","year":"2016","unstructured":"Mithoowani S, Gregory-Miller K, Goy J, et al. High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis. Lancet Haematol. 2016;3(10):e489\u201396.","journal-title":"Lancet Haematol"}],"container-title":["Canadian Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43678-025-01024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43678-025-01024-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43678-025-01024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:18:48Z","timestamp":1772551128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43678-025-01024-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1024"],"URL":"https:\/\/doi.org\/10.1007\/s43678-025-01024-y","relation":{},"ISSN":["1481-8035","1481-8043"],"issn-type":[{"value":"1481-8035","type":"print"},{"value":"1481-8043","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Khalife receives grants\/contracts from the Canadian Hemophilia Society, Canadian Blood Services, and Association of Hemophilia Clinic Directors of Canada. He has received consulting fees from CSL Behring. He has received payment\/honoria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Bayer, CSL Behring, Novo Nordisk, Takeda, Pfizer, Roche, and Sandofi. These did not impact the construction of this manuscript. Dr. Rosenberg has received payment\/honoria for expert testimony, lectures, presentations, speakers bureaus, manuscript writing or educational events as a Medical Expert\u2014Canadian Medical Protective Association. These did not impact the construction of this manuscript. Dr. Long has no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}